Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00018785 · ClinicalTrials.gov registry record · NA

Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase

NCT00018785: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00018785 is a NA study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00018785, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase

Study Summary

Diabetes and end-stage kidney, liver and heart disease are prominent health issues among veteran patients. Successful solid organ transplantation in the absence of chronic immunosuppressive therapy (specific acquired immunological tolerance) is a desirable therapeutic option. This project extends recent observations supporting the use of concommitant donor bone marrow cell infusion as a means of modulating the immune response in kidney transplantation, thereby allowing a substantial decrease or withdrawal of potentially toxic immunosuppressive drugs.

Interventions

  • PROCEDURE donor bone marrow infusion

Trial Details

FieldValue
Start Date 1998-10
Est. Completion 2003-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00018785 record still lists

NCT00018785 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which donor bone marrow infusion is the first listed.

NCT00018785 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00018785 about?

NCT00018785 is a clinical study titled "Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants". Diabetes and end-stage kidney, liver and heart disease are prominent health issues among veteran patients. Successful solid organ transplantation in the absence of chronic immunosuppressive therapy (specific acquired immunological tolerance) is a desirable therapeutic option. This project extends re...

What is the current status of trial NCT00018785?

This trial is currently completed. It is a NA study. The study started on 1998-10. Estimated completion is 2003-09.

What interventions are being tested in trial NCT00018785?

The interventions under investigation include: donor bone marrow infusion (PROCEDURE).

Who is sponsoring clinical trial NCT00018785?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00018785, the US trial registry maintained by the National Library of Medicine. NCT00018785 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.